Screener

Net loss

Name: Summit Therapeutics Net loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Summit Therapeutics·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$62.91M	-$565.71M	-$231.79M	-$219.17M	-$189.42M
Total	-$62.91M	-$565.71M	-$231.79M	-$219.17M	-$189.42M

Business SegmentsView metric